(lp0
S'Company Update : Hemispherx BioPharma, Inc Meets Ampligen Sales ... Smarter Analyst - Mar 6, 2017 Hemispherx BioPharma, Inc  announced today that it has met a major milestone, the commencement of sales of recently manufactured Ampligen in international programs.Hemispherx Biopharma, Inc. Meets Ampligen Sales Milestone in the 1st Quarter ... - GlobeNewswire Stock Performance Review: Hemispherx Biopharma, Inc.  - The Oracle Examiner'
p1
aS"Breaking Down The Hemispherx BioPharma, Inc  Catalsysts Insider Financial - Feb 3, 2017 Hemispherx BioPharma, Inc  took a hit of more than 30% at the end of this week, on the company's announcement that it is set to raise $1 million by way of a registered direct offering .HEMISPHERX BIOPHARMA, INC.  Files An 8-K Entry into a Material ... - Market ExclusiveStock Alert: Hemispherx Biopharma, Inc.  - TopChronicle"
p2
aS"Company Update : Here Why Shares of Hemispherx BioPharma, Inc Rose 9% Smarter Analyst - Jan 11, 2017 Hemispherx BioPharma, Inc  announced that the rintatolimod European early access program  designed to enable access of the compound to ME/CFS patients has been extended to pancreatic cancer patients beginning in the&nbsp;...European early access program for Hemispherx Bio's rintatolimod expanded to ... - Seeking Alpha"
p3
aS'Hemispherx Biopharma Announces 1-for-12 Reverse Stock Split GlobeNewswire  - Aug 17, 2016 Hemispherx Biopharma, Inc. is an advanced specialty pharmaceutical company engaged in the manufacture and clinical development of new drug entities for treatment of seriously debilitating disorders.'
p4
aS"Hemispherx BioPharma CEO Talks About Ampligen, Alferon's Potential Benzinga - Jan 3, 2017 Hemispherx BioPharma, Inc  is a nano-cap biopharmaceutical research and development company that focuses on the treatment of seriously debilitating disorders."
p5
aS"Company Update : Here's Why Hemispherx BioPharma, Inc Shares Are ... Smarter Analyst - Feb 2, 2017 This morning, Hemispherx BioPharma, Inc  announced that it has entered into definitive agreements with several institutional investors for an offering of shares of common stock with gross proceeds of approximately $1 million in a ..."
p6
aS'Hemispherx Biopharma: Catalysts For A Turnaround Seeking Alpha - Jun 10, 2015 Hemispherx Biopharma, Inc.  has been in the news lately for a variety of reasons that may be of interest to investors.'
p7
aS'Hemispherx BioPharma Inc  Making A Comeback Insider Financial - Mar 8, 2016 Hemispherx BioPharma Inc  is one biotech name that has desperately been in need of few changes. It looks like investors are going to get the turnaround needed after the company finally fired longtime Chairman &amp; CEO Dr.'
p8
aS'Stock Update : Hemispherx BioPharma, Inc Announces First ... Smarter Analyst - Jan 26, 2017 Hemispherx BioPharma, Inc  announced that an order of newly manufactured rintatolimod  for sale utilizing the Early Access Program  in Europe has been shipped with receipt confirmed on January 26.'
p9
aS"Hemispherx Biopharma, Inc. : Thoughts on the Momentum Post Analyst - 23 hours ago Hemispherx Biopharma, Inc.  traded at an unexpectedly low level on 03/27/2017 when the stock experienced a 8.72 gain to a closing price of $0.55.Stocks in Analyst's Viewfinder: Hemispherx Biopharma, Inc.  iCAD, Inc ... - Rives JournalHemispherx Biopharma, Inc.'s , a stock from Healthcare sector has a most ... - Street Updates"
p10
a.